Register entry
CSL Behring GmbH
- Registered sites
- 0
- Drug products
- 67
- Live patents
- 0
- Countries
- 0
- Base
- Unknown
Sites
Facilities
0No registered facilities
This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.
Catalogue
Marketed products
67Showing 67 of 67.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| ALBURX | ALBUMIN (HUMAN) | SOLUTION | BLA |
| AlbuRx | ALBUMIN (HUMAN) | SOLUTION | BLA |
| Berinert | HUMAN C1-ESTERASE INHIBITOR | KIT | BLA |
| Corifact | Factor XIII Concentrate (Human) | KIT | BLA |
| HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human) | HUMAN C1-ESTERASE INHIBITOR | KIT | BLA |
| HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human) | HUMAN C1-ESTERASE INHIBITOR | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| HEMGENIX | etranacogene dezaparvovec | KIT | BLA |
| Hizentra | HUMAN IMMUNOGLOBULIN G | LIQUID | BLA |
| Hizentra | HUMAN IMMUNOGLOBULIN G | LIQUID | BLA |
| Hizentra | HUMAN IMMUNOGLOBULIN G | LIQUID | BLA |
| Hizentra | HUMAN IMMUNOGLOBULIN G | LIQUID | BLA |
| Hizentra | HUMAN IMMUNOGLOBULIN G | LIQUID | BLA |
| Hizentra | HUMAN IMMUNOGLOBULIN G | LIQUID | BLA |
| Hizentra | HUMAN IMMUNOGLOBULIN G | LIQUID | BLA |
| Humate-P | antihemophilic factor/von willebrand factor complex (human) | KIT | BLA |
| Humate-P | antihemophilic factor/von willebrand factor complex (human) | KIT | BLA |
| Humate-P | antihemophilic factor/von willebrand factor complex (human) | KIT | BLA |
| Kcentra | PROTHROMBIN, COAGULATION FACTOR VII HUMAN, COAGULATION FACTOR IX HUMAN, COAGULATION FACTOR X HUMAN, Protein C, Protein S Human, and Water | KIT | BLA |
| Kcentra | PROTHROMBIN, COAGULATION FACTOR VII HUMAN, COAGULATION FACTOR IX HUMAN, COAGULATION FACTOR X HUMAN, Protein C, Protein S Human, and Water | KIT | BLA |
| Privigen | Human Immunoglobulin G | LIQUID | BLA |
| Privigen | Human Immunoglobulin G | LIQUID | BLA |
| Privigen | Human Immunoglobulin G | LIQUID | BLA |
| Privigen | Human Immunoglobulin G | LIQUID | BLA |
| Rhophylac | HUMAN RHO(D) IMMUNE GLOBULIN | SOLUTION | BLA |
| RiaSTAP | FIBRINOGEN HUMAN | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | BLA |
| Riastap | FIBRINOGEN HUMAN | INJECTION, SOLUTION | BLA |
| ZEMAIRA | .ALPHA.1-PROTEINASE INHIBITOR HUMAN | KIT | BLA |
| ZEMAIRA | .ALPHA.1-PROTEINASE INHIBITOR HUMAN | KIT | BLA |
| Zemaira | alpha-1-proteinase inhibitor human | KIT | BLA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.